Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
44816808	li-cxcl13	— (—)	1471	1570	100.00%	Distribution not available
44816808	li-cxcl13	pg/ml (ng/l)	536	581	3.96%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Spirochaetal infections, other/unspecified

333

121

30.09

307.65

1.1

1123.48

373.26

ng/l

1.04

107

Inflammatory diseases of the central nervous system

258

115

24.07

307.65

1.2

1.1

302.99

435.50

ng/l

0.22

131

Spirochaetal infections, other/unspecified, including avohilmo

420

543

7.90

303.87

1.1

994.09

307.72

ng/l

1.17

125

140

Other spirochaetal diseases

419

545

7.86

301.58

1.1

986.20

307.72

ng/l

1.16

126

140

Other spirochaetal diseases, including avohilmo

421

551

7.81

301.39

1.1

986.20

307.72

ng/l

1.16

126

140

Lyme disease

418

543

7.87

301.20

1.1

994.09

309.68

ng/l

1.16

125

139

Lyme disease, including avohilmo

418

543

7.87

301.20

1.1

994.09

309.68

ng/l

1.16

125

139

Encephalitis

143

43.77

237.09

1.2

1.1

218.19

28.63

ng/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

509

1030

5.00

234.36

1.1

116.19

555.33

ng/l

1.94

133

290

Other encephalitis

139

45.21

232.15

1.2

1.1

226.57

17.50

ng/l

—

Viral infections of the central nervous system, including avohilmo

191

118

17.09

227.75

1.2

1.1

96.90

255.35

ng/l

0.77

Neurological diseases

473

341

7.01

221.16

1.1

189.86

160.53

ng/l

0.14

126

Viral infections of the central nervous system

180

112

16.99

213.90

1.2

1.1

98.20

265.70

ng/l

0.80

Polyneuropathies and other disorders of the peripheral nervous system

258

337

7.83

185.24

1.1

462.90

400.48

ng/l

0.11

Headache

462

753

4.78

184.90

1.1

214.10

482.44

ng/l

0.66

105

203

Other symptoms and signs involving the nervous and musculoskeletal systems

370

718

5.22

179.08

1.1

73.30

407.59

ng/l

1.70

101

193

Other degenerative diseases of the nervous system

208

127

12.08

172.53

1.1

71.24

287.69

ng/l

0.94

Other and unspecified polyneuropathies, also in other diseases

223

287

7.94

162.21

1.1

523.34

437.70

ng/l

0.13

Meningitis

125

20.10

160.74

1.2

1.1

498.60

32.54

ng/l

2.23

Symptoms and signs involving cognition, perception, emotional state and behaviour

620

1186

3.52

158.82

1.1

256.41

489.56

ng/l

0.83

133

351

Abnormal findings on diagnostic imaging of central nervous system

113

18.88

141.57

1.2

1.1

320.60

284.59

ng/l

0.05

Other symptoms and signs involving cognitive functions and awareness

334

629

4.75

139.62

1.1

280.32

714.56

ng/l

0.95

193

Epilepsy

255

448

5.74

137.13

1.1

617.52

178.13

ng/l

0.64

119

Bell's palsy

157

169

9.53

131.91

1.1

778.77

274.58

ng/l

0.68

Fever of other and unknown origin

350

698

4.37

131.51

1.1

350.02

515.74

ng/l

0.27

122

191

General symptoms and signs

561

819

3.45

125.95

1.1

303.04

471.81

ng/l

0.34

158

223

Malaise and fatigue

316

567

4.42

116.41

1.1

153.72

524.90

ng/l

0.84

162

Status epilepticus

25.95

112.95

1.2

1.0

44.42

131.29

ng/l

—

Certain infectious and parasitic diseases

473

666

3.57

111.72

1.1

410.68

63.50

ng/l

1.42

137

132

Disturbances of skin sensation

242

506

4.85

107.68

1.1

533.53

207.09

ng/l

0.30

144

Neurological diseases, wide definition

164

12.02

106.44

1.1

1.0

198.24

116.53

ng/l

0.37

Intracranial trauma

225

275

5.55

100.52

1.1

81.76

180.33

ng/l

0.83

Concussion

197

272

5.64

94.95

1.1

78.15

183.24

ng/l

0.88

Visual disturbances and blindness

340

1011

3.39

92.91

1.1

679.80

357.50

ng/l

0.47

283

Convulsions, not elsewhere classified

169

299

5.64

89.15

1.1

66.45

251.29

ng/l

1.23

Demyelinating diseases of the central nervous system

113

137

8.47

86.61

1.1

82.92

318.52

ng/l

0.83

Nerve, nerve root and plexus disorders

552

1257

2.65

85.96

1.1

406.59

420.94

ng/l

0.03

143

352

Focal epilepsy, strict definition

173

336

5.22

83.99

1.2

1.1

555.52

321.36

ng/l

0.22

Focal epilepsy

181

368

4.98

83.33

1.2

1.1

523.20

300.15

ng/l

0.23

Visual disturbances

309

930

3.35

83.08

1.1

707.39

372.33

ng/l

0.44

263

Focal epilepsy, mode (most common among epilepsy diagnosis)

163

317

5.22

79.04

1.2

1.1

570.93

344.00

ng/l

0.20

Other neurological diseases

397

1082

2.86

76.71

1.2

1.1

378.52

500.53

ng/l

0.20

106

295

Medical observation and evaluation for suspected diseases and conditions

332

493

3.46

75.80

1.1

531.01

347.14

ng/l

0.26

149

Dizziness and giddiness

379

1020

2.90

75.33

1.1

277.10

501.54

ng/l

0.64

103

311

Other demyelinating diseases of the central nervous system

14.54

73.61

1.1

116.26

391.08

ng/l

0.48

Episodal and paroxysmal disorders

503

984

2.60

71.97

1.1

426.16

266.60

ng/l

0.40

126

267

Symptoms and signs involving the skin and subcutaneous tissue

387

1371

2.68

69.40

1.1

489.72

402.24

ng/l

0.12

384

Condition for Implicit Sepsis (Organ dysfunction codes)

437

1179

2.58

67.46

1.1

430.50

456.19

ng/l

0.04

340

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

452

1212

2.53

66.56

1.1

414.47

449.99

ng/l

0.05

100

346

Migraine

274

657

3.26

66.32

1.1

190.61

130.07

ng/l

0.33

178

Viral meningitis, including avohilmo

14.06

65.86

1.1

107.96

386.75

ng/l

0.52

Viral meningitis

14.59

65.00

1.2

1.1

107.96

386.75

ng/l

0.52

Implicit Sepsis, including avohilmo

419

1173

2.56

64.44

1.1

451.86

432.68

ng/l

0.03

340

Diplopia

109

183

6.05

62.03

1.2

1.1

1651.28

216.50

ng/l

1.09

Abnormalities of gait and mobility

101

162

6.33

60.18

1.1

319.50

323.52

ng/l

0.00

MS-disease / Multiple Sclerosis

102

8.12

60.18

1.1

37.27

263.10

ng/l

0.78

Postprocedural disorders of nervous system

100

8.18

59.80

1.1

20.88

245.62

ng/l

0.82

Infections, IBD-co-morbidities

12.43

59.48

1.1

1.0

287.60

127.14

ng/l

0.40

Pain, not elsewhere classified

151

354

4.30

58.38

1.1

552.15

231.99

ng/l

0.31

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

137

124

5.57

53.42

1.1

197.16

278.43

ng/l

0.26

Disorders of optic nerve and visual pathways

154

6.08

52.61

1.2

1.1

73.55

199.60

ng/l

0.78

Implicit Sepsis

367

1117

2.43

51.12

1.1

491.61

449.18

ng/l

0.05

315

Cerebrovascular diseases (FINNGEN)

193

393

3.47

49.72

1.1

381.26

249.56

ng/l

0.27

104

Speech disturbances, not elsewhere classified

133

6.27

48.41

1.2

1.1

367.44

367.00

ng/l

0.00

Implicit viral Sepsis, including avohilmo

176

525

3.37

48.07

1.1

146.10

336.32

ng/l

0.76

136

Low back pain

350

975

2.43

47.84

1.1

331.80

370.85

ng/l

0.08

290

Certain infectious and parasitic diseases, including avohilmo

278

487

2.87

47.53

1.1

318.33

81.83

ng/l

1.43

Other soft tissue disorders, not elsewhere classified

425

1076

2.25

46.89

1.1

410.07

334.49

ng/l

0.13

312

Dorsalgia

428

1006

2.26

46.63

1.1

638.76

364.11

ng/l

0.53

296

Cerebrovascular diseases

342

986

2.42

46.38

1.1

518.00

505.51

ng/l

0.02

277

Viral Sepsis

134

344

3.93

46.01

1.2

1.1

166.84

471.33

ng/l

0.82

Implicit viral Sepsis

133

343

3.91

45.38

1.2

1.1

166.84

471.33

ng/l

0.82

Other headache syndromes

195

653

2.99

43.78

1.1

67.56

172.55

ng/l

1.40

185

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

313

1154

2.37

42.98

1.1

248.36

516.27

ng/l

0.84

313

Other disorders of optic [2nd] nerve and visual pathways

7.18

42.84

1.2

1.1

44.69

213.57

ng/l

0.83

Pain in joint

249

558

2.75

42.37

1.1

203.12

444.46

ng/l

0.52

176

Migraine without aura

116

288

4.06

41.71

1.1

42.00

59.95

ng/l

0.35

General examination and investigation of persons without complaint and reported diagnosis

259

493

2.74

41.37

1.1

328.20

347.14

ng/l

0.03

149

Bacterial infection, other or unspecified

260

870

2.53

40.95

1.2

1.1

559.51

532.03

ng/l

0.03

219

STROKE

278

757

2.48

39.77

1.1

359.07

452.26

ng/l

0.15

205

Myalgia

138

404

3.44

39.10

1.1

85.09

247.52

ng/l

1.82

119

Disorders of thyroid, IBD co-morbidities

8.82

39.09

1.1

819.71

118.27

ng/l

0.53

Other dorsopathies, not elsewhere classified

412

1007

2.13

38.90

1.1

573.56

364.11

ng/l

0.37

296

Bacterial infection, other or unspecified, including avohilmo

280

963

2.39

38.84

1.2

1.1

531.93

498.80

ng/l

0.04

101

248

ILD medications: prednisolone, methylprednisolone, prednisone

451

1233

2.04

38.73

1.1

341.52

474.17

ng/l

0.30

131

309

Lower back pain or/and sciatica

459

1436

1.99

38.10

1.1

336.09

422.73

ng/l

0.22

106

405

ILD medications

466

1258

2.00

37.81

1.1

306.41

471.61

ng/l

0.41

140

311

GASTRO-related operations

317

676

2.36

37.48

1.1

245.80

175.54

ng/l

0.27

165

Any gastric operation

317

676

2.36

37.48

1.1

245.80

175.54

ng/l

0.27

165

Autoimmune diseases excluding thyroid diseases

443

1186

2.03

37.40

1.1

238.49

389.96

ng/l

0.53

154

286

Examination and observation for other reasons

233

490

2.69

37.18

1.1

456.33

351.18

ng/l

0.20

147

Malignant neoplasm of brain, including Hilmo

7.52

36.97

1.2

1.1

686.14

99.66

ng/l

0.71

Autoimmune diseases excluding thyroid diseases, strict definition

429

1146

2.04

36.83

1.1

244.75

397.01

ng/l

0.51

148

278

Pain in limb

357

1054

2.16

36.78

1.1

453.54

337.35

ng/l

0.18

309

ILD medications: immunosuppressive drugs

293

1176

2.26

36.68

1.1

239.35

495.17

ng/l

0.81

102

293

Subjective visual disturbances

142

441

3.24

36.65

1.1

50.50

247.94

ng/l

2.35

110

Malignant neoplasm of brain

9.07

36.44

1.2

1.1

847.53

130.30

ng/l

0.70

Paralytic strabismus

6.33

36.41

1.1

725.55

266.08

ng/l

0.46

Oral corticosteroids

444

1319

1.98

35.71

1.1

357.10

454.77

ng/l

0.21

128

345

Cerebral cysts

7.25

35.21

1.2

1.1

1777.83

291.50

ng/l

0.39

Autoimmune diseases related-to ILD

370

1522

2.04

34.83

1.1

177.28

467.87

ng/l

1.34

126

383

Pain (limb, back, neck, head abdominally)

274

569

2.42

34.24

1.1

385.41

444.59

ng/l

0.08

175

Optic neuritis

8.79

34.10

1.2

1.1

109.28

47.55

ng/l

0.48

Stroke, including SAH

270

839

2.32

33.95

1.1

498.60

577.78

ng/l

0.09

226

Small fibre neuropathy

10.31

33.74

1.1

31.00

413.22

ng/l

—

Implicit bacterial Sepsis, including avohilmo

206

671

2.56

33.32

1.2

1.1

707.07

464.81

ng/l

0.26

192

Stroke, excluding SAH

257

793

2.35

33.32

1.1

504.89

593.42

ng/l

0.10

218

Cerebral palsy and other paralytic syndromes

179

4.52

33.09

1.1

172.10

352.46

ng/l

0.55

Inflammatory bowel disease treatment related agents

466

1362

1.90

33.09

1.1

291.80

447.69

ng/l

0.41

136

351

Abnormal involuntary movements

185

4.42

32.63

1.1

527.07

370.08

ng/l

0.13

Ischaemic Stroke, excluding all haemorrhages

240

742

2.39

32.53

1.2

1.1

277.36

577.15

ng/l

0.62

209

Dorsopathies

401

1016

2.00

32.21

1.1

261.41

363.14

ng/l

0.26

297

Implicit bacterial Sepsis

189

621

2.62

32.19

1.2

1.1

730.71

500.71

ng/l

0.23

177

Enlarged lymph nodes

192

4.30

31.97

1.1

400.04

223.92

ng/l

0.34

Migraine with aura

117

352

3.34

31.80

1.1

276.68

100.73

ng/l

0.63

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

105

5.71

31.76

1.1

655.68

150.62

ng/l

0.62

Syncope and collapse

171

526

2.72

31.24

1.1

738.30

557.08

ng/l

0.11

152

Other antidepressants

409

1066

1.96

31.16

1.1

458.29

371.04

ng/l

0.16

102

311

Malignant neoplasm of eye, brain and central nervous system

7.23

31.01

1.2

847.53

111.99

ng/l

0.73

First line medication for Crohn's disease

435

1231

1.91

30.85

1.1

555.20

356.09

ng/l

0.35

123

306

Dysphagia

124

396

3.15

30.63

1.2

1.1

437.77

561.69

ng/l

0.12

108

Radiculopathy

221

3.97

30.46

1.1

479.18

234.89

ng/l

0.25

Bacterial Sepsis

206

698

2.45

30.31

1.2

1.1

660.55

449.65

ng/l

0.24

199

Alzheimer disease, excluding more controls

6.20

29.90

1.1

25.25

464.57

ng/l

0.97

Provisional assignment of new diseases of uncertain etiology

235

1036

2.26

29.85

1.1

89.41

321.91

ng/l

1.57

282

Codes for special purposes

235

1038

2.25

29.71

1.1

89.41

321.91

ng/l

1.57

282

Diseases of the eye and adnexa

319

756

2.12

29.63

1.1

190.75

266.09

ng/l

0.26

187

Persons encountering health services for specific procedures and health care

436

1387

1.86

29.43

1.1

305.27

457.05

ng/l

0.32

121

353

Other bacterial diseases

387

1341

1.92

29.36

1.1

529.99

403.54

ng/l

0.24

125

343

Visual impairment including blindness (binocular or monocular)

6.32

28.70

1.1

280.00

68.00

ng/l

0.99

Other special examinations and investigations of persons without complaint or reported diagnosis

231

493

2.38

28.11

1.1

459.51

347.14

ng/l

0.22

149

Opioids

380

1015

1.94

28.08

1.1

401.24

358.77

ng/l

0.06

295

Diagnoses used for exclusion with ILD

128

439

2.93

27.99

1.2

1.1

291.28

347.99

ng/l

0.09

115

Symptoms and signs involving speech and voice

160

624

2.58

27.34

1.1

266.58

434.88

ng/l

0.34

165

Systemic connective tissue disorders

162

646

2.52

26.45

1.1

185.09

466.97

ng/l

0.97

173

Used for control exclusion in common control thyroid runs

398

1083

1.86

25.83

1.1

274.55

391.70

ng/l

0.30

117

261

Delirium, not induced by alcohol and other psychoactive substances

171

4.12

25.81

1.1

248.33

369.06

ng/l

0.20

Other specific joint derangements/joint disorders

313

992

1.97

25.52

1.1

181.49

348.74

ng/l

0.77

292

Somatoform disorder

255

3.48

25.52

1.1

38.18

284.47

ng/l

1.47

Anxiety disorders, excluding more controls

327

1085

1.93

25.26

1.1

220.64

366.41

ng/l

0.46

309

Covid-19 confirmed case

165

679

2.44

25.11

1.1

104.98

340.49

ng/l

1.46

180

Spondylopathies

291

857

2.01

24.83

1.1

836.58

388.51

ng/l

0.68

261

Certain disorders involving the immune mechanism

105

349

3.03

24.36

1.2

1.1

540.42

291.21

ng/l

0.33

Migraine without aura and triptan purchases

279

3.29

24.17

1.1

46.67

522.83

ng/l

1.02

Tramadol

303

933

1.96

24.05

1.1

773.26

377.49

ng/l

0.57

277

Non-Hodgkin lymphoma, all, including Hilmo

220

3.58

23.62

1.2

1.1

1531.85

403.02

ng/l

1.11

Other disorders of eye and adnexa

249

3.40

23.56

1.2

1.1

235.57

331.26

ng/l

0.19

Strabismus

132

504

2.63

23.49

1.1

350.34

184.99

ng/l

0.34

122

Organic, including symptomatic, mental disorders

204

648

2.22

23.37

1.1

301.64

613.05

ng/l

0.57

198

Nausea and vomiting

121

432

2.74

23.37

1.2

1.1

303.67

808.20

ng/l

0.61

117

Diffuse large B-cell lymphoma, including Hilmo

6.17

23.32

1.3

1.1

1818.04

43.64

ng/l

1.13

Diffuse large B-cell lymphoma

6.17

23.32

1.3

1.1

1818.04

43.64

ng/l

1.13

Diffuse large B-cell lymphoma, helper endpoint

6.17

23.32

1.3

1.1

1818.04

43.64

ng/l

1.13

Other diseases of spinal cord

8.52

23.20

1.2

1.1

80.00

171.90

ng/l

—

Sciatica+with lumbago

204

836

2.17

23.12

1.1

417.19

387.32

ng/l

0.04

258

Neurotic, stress-related and somatoform disorders

356

1359

1.81

22.94

1.1

206.56

472.96

ng/l

0.91

373

Recurrent or chronic depression

164

470

2.43

22.90

1.1

1328.69

411.13

ng/l

0.38

142

Autoimmune diseases

414

1194

1.76

22.89

1.1

295.52

389.96

ng/l

0.23

126

286

Persons encountering health services for examination and investigation

217

493

2.21

22.54

1.1

342.86

347.14

ng/l

0.01

149

Other intervertebral disc disorders

294

913

1.92

22.24

1.1

250.12

385.58

ng/l

0.29

277

Anxiety disorders

357

1372

1.79

22.21

1.1

206.56

468.10

ng/l

0.90

379

Other bacterial diseases, including avohilmo

389

1389

1.75

22.10

1.1

500.92

398.52

ng/l

0.19

125

350

Non-follicular lymphoma

148

4.10

22.01

1.2

1.1

1667.77

366.92

ng/l

1.02

Benzodiazepine use

386

1501

1.74

21.76

1.1

745.37

339.01

ng/l

0.42

423

Liquid cancers

132

495

2.54

21.68

1.2

1.1

1052.61

730.67

ng/l

0.27

126

Disorders of ocular muscles, binocular movement, accommodation and refraction

207

991

2.08

21.52

1.1

421.25

305.95

ng/l

0.20

260

Soft tissue disorders

376

1085

1.78

21.49

1.1

431.31

333.66

ng/l

0.15

313

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

380

1483

1.73

21.06

1.1

557.32

369.06

ng/l

0.34

118

384

Abnormalities of breathing

336

1063

1.81

20.98

1.1

470.40

267.35

ng/l

0.46

294

Other viral diseases, including avohilmo

170

762

2.22

20.88

1.1

66.82

287.41

ng/l

1.20

193

Diseases of the myoneural junction and muscle

195

3.57

20.88

1.2

1.1

404.32

190.98

ng/l

0.28

Symptoms and signs involving the digestive system and abdomen

367

1038

1.78

20.77

1.1

272.12

523.43

ng/l

0.72

282

Symptoms and signs involving the urinary system

296

1216

1.84

20.62

1.1

508.76

435.33

ng/l

0.10

345

Codeine

335

1003

1.81

20.53

1.1

174.88

360.96

ng/l

0.60

293

Other/unspecified dorsalgia

145

611

2.35

20.47

1.1

489.00

427.15

ng/l

0.07

198

Oedema, not elsewhere classified

112

414

2.65

20.34

1.2

1.1

386.11

549.57

ng/l

0.15

117

Second line medication for Crohn's disease

238

1241

1.92

19.93

1.2

1.1

292.66

502.88

ng/l

0.59

332

Viral infections characterized by skin and mucous membrane lesions

180

850

2.12

19.90

1.2

1.1

233.82

366.62

ng/l

0.46

228

Primary_lymphoid and hematopoietic malignant neoplasms

109

414

2.65

19.81

1.2

1.1

1206.73

360.60

ng/l

1.07

104

Other disorders of lacrimal gland

161

731

2.21

19.72

1.1

819.55

476.21

ng/l

0.28

204

Mood disorders, excluding more controls

343

1146

1.76

19.72

1.1

573.60

352.37

ng/l

0.20

333

Trigeminal neuralgia

5.34

19.67

1.1

1123.50

131.11

ng/l

—

Cardiovascular diseases

236

626

2.01

19.55

1.1

187.26

196.06

ng/l

0.03

157

Sarcoidosis

229

3.26

19.47

1.2

1.1

477.73

369.89

ng/l

0.09

Parasetamol

264

693

1.93

19.40

1.1

199.87

375.72

ng/l

0.51

181

Cervicalgia

318

2.88

19.39

1.1

864.11

428.03

ng/l

0.22

Pneumonitis due to solids and liquids

115

4.30

19.21

1.2

1.1

100.20

197.15

ng/l

0.42

Exclusions for E4_PCOS_BROAD

331

2.83

19.15

1.1

549.93

239.75

ng/l

0.55

Ocular pain

137

3.98

19.11

1.2

1.1

365.31

388.73

ng/l

0.02

Sixth [abducent] nerve palsy

6.65

18.80

1.0

423.70

94.78

ng/l

—

Asthma, excluding more controls

261

705

1.90

18.57

1.1

136.39

488.89

ng/l

0.85

181

Parkinson's disease, excluding more controls

5.24

18.38

1.1

101.40

405.88

ng/l

—

L04AX Other immunosuppressants

227

1201

1.89

18.27

1.2

1.1

311.61

514.97

ng/l

0.53

322

Abdominal and pelvic pain

355

1038

1.72

18.16

1.1

249.91

523.43

ng/l

0.80

282

Non-Hodgkin lymphoma, all

5.77

18.07

1.3

1.2

2121.89

98.92

ng/l

1.03

Asthma (mode)

264

741

1.88

18.06

1.1

152.94

501.14

ng/l

0.87

191

Neuralgia and neuritis, unspecified

5.14

17.90

1.1

499.00

350.49

ng/l

—

Other reaction to severe stress, and adjustment disorders

152

702

2.17

17.85

1.1

443.54

320.56

ng/l

0.17

183

Other necrotizing vasculopathies (FG)

4.77

17.76

1.2

1.1

189.00

456.07

ng/l

0.44

Cervical disc disorders

139

621

2.25

17.76

1.1

472.23

443.72

ng/l

0.03

192

Disorders of lacrimal system

181

882

2.03

17.66

1.1

697.36

427.54

ng/l

0.26

244

Asthma

264

733

1.86

17.59

1.1

134.41

506.24

ng/l

0.96

189

Other disorders of fluid, electrolyte and acid-base balance

129

527

2.31

17.47

1.1

431.64

816.69

ng/l

0.55

133

Other viral diseases, not elsewhere classified, including avohilmo

124

528

2.34

17.47

1.0

1.1

76.37

354.32

ng/l

0.99

133

Other systemic involvement of connective tissue (FG)

110

438

2.48

17.44

1.1

80.18

839.48

ng/l

1.51

127

Other functional intestinal disorders

185

840

2.01

17.36

1.1

226.29

414.43

ng/l

0.58

221

Extrapyramidal and movement disorders

152

712

2.14

17.29

1.1

1182.32

429.39

ng/l

0.37

189

Pain in throat and chest

308

1047

1.74

17.23

1.1

377.78

268.94

ng/l

0.16

292

Gastro-oesophageal reflux disease

265

1254

1.79

17.23

1.1

314.19

478.74

ng/l

0.39

352

Parkinson's disease, strict definition, excluding more controls

5.29

17.19

1.1

101.40

426.75

ng/l

—

Anaemias

184

2.97

17.12

1.1

109.20

243.35

ng/l

0.51

Systemic atrophies primarily affecting the central nervous system

5.41

16.87

1.1

1.0

14.82

247.99

ng/l

—

Herpesviral [herpes simplex] infections

194

3.27

16.76

1.2

1.1

301.92

353.85

ng/l

0.09

Zoster [herpes zoster]

294

2.81

16.74

1.1

250.17

333.55

ng/l

0.26

Depression medications

103

190

2.73

16.61

1.1

70.79

233.93

ng/l

0.72

Liquid cancers, including Hilmo

146

599

2.16

16.50

1.2

1.1

997.79

613.11

ng/l

0.39

153

Cardiovascular diseases (excluding rheumatic etc)

238

733

1.86

16.33

1.1

133.94

222.07

ng/l

0.63

187

Chronic laryngitis and laryngotracheitis

223

3.07

16.30

1.1

763.94

643.89

ng/l

0.06

Other diseases of intestines

385

1326

1.62

16.19

1.1

263.98

371.69

ng/l

0.41

349

Other disorders of urethra and urinary system

255

999

1.78

15.84

1.1

419.80

267.00

ng/l

0.18

280

Spondylosis

192

778

1.93

15.81

1.1

303.02

421.52

ng/l

0.22

238

Other necrotizing vasculopathies

102

4.16

15.81

1.1

192.35

472.37

ng/l

0.48

Finngen Rheumatological endpoints

347

1195

1.65

15.79

1.1

135.89

446.22

ng/l

1.53

335

Sequelae of cerebrovascular disease

131

507

2.21

15.75

1.1

181.10

336.32

ng/l

0.55

142

Other viral diseases

126

567

2.22

15.74

1.1

80.47

192.52

ng/l

1.05

143

Alzheimer’s disease (Early onset), excluding more controls

13.55

15.73

1.1

15.00

165.33

ng/l

—

Other systemic involvement of connective tissue

112

482

2.33

15.70

1.1

77.22

413.84

ng/l

1.20

128

Symptoms and signs involving the circulatory and respiratory systems

351

1066

1.65

15.60

1.1

241.04

266.52

ng/l

0.07

295

Influenza and pneumonia

384

1488

1.59

15.50

1.1

415.67

407.39

ng/l

0.01

109

383

Codeine or tramadol medication

396

1355

1.59

15.38

1.1

340.57

437.76

ng/l

0.17

393

Complications of surgical and medical care, not elsewhere classified

359

1490

1.61

15.32

1.1

110.75

478.73

ng/l

2.56

413

Traumatic subdural haemorrhage

5.00

15.27

1.2

1.1

164.08

243.00

ng/l

0.20

Other extrapyramidal and movement disorders in other diseases

105

445

2.37

15.26

1.1

1400.44

293.89

ng/l

0.49

118

Explicit Sepsis, including avohilmo

161

730

2.00

15.15

1.1

637.07

447.92

ng/l

0.16

202

Fitting and adjustment of other devices

137

569

2.13

15.02

1.1

68.19

790.74

ng/l

1.91

150

Intracranial injury

218

1131

1.80

14.88

1.1

94.06

545.82

ng/l

2.33

314

Other and unspecified visual disturbances

159

3.36

14.74

1.1

56.62

282.42

ng/l

1.13

Diseases of the musculoskeletal system and connective tissue

180

453

2.00

14.68

1.1

195.56

154.66

ng/l

0.15

139

Alzheimer’s disease (Early onset)

5.68

14.62

1.1

15.00

312.68

ng/l

—

COPD differential diagnosis

260

741

1.76

14.54

1.1

310.60

501.14

ng/l

0.35

191

ILD differential diagnosis

260

741

1.76

14.54

1.1

310.60

501.14

ng/l

0.35

191

Oxycodone

147

616

2.05

14.50

1.1

1009.37

451.28

ng/l

0.47

188

Injuries to the head

400

1527

1.56

14.49

1.1

97.52

469.16

ng/l

2.65

411

Asthma, unspecified (mode), excluding more controls

178

660

1.93

14.47

1.1

229.90

524.04

ng/l

0.54

165

Asthma, unspecified (mode)

182

687

1.92

14.43

1.1

226.54

541.37

ng/l

0.63

173

Explicit Sepsis

155

710

1.99

14.40

1.1

650.87

452.08

ng/l

0.17

198

Mood disorders

364

1474

1.58

14.35

1.1

566.25

384.97

ng/l

0.16

413

Depression

344

1441

1.60

14.31

1.1

638.48

392.09

ng/l

0.21

404

Mood [affective] disorders

363

1474

1.58

14.26

1.1

573.18

386.06

ng/l

0.16

413

Metabolic disorders

334

1242

1.62

14.21

1.1

419.15

463.58

ng/l

0.06

326

Immunodeficiency with predominantly antibody defects

6.79

14.06

1.1

693.67

359.50

ng/l

—

Unknown and unspecified causes of morbidity

4.95

14.04

1.1

67.86

151.24

ng/l

—

Cervicobrachial syndrome

346

2.50

14.03

1.1

121.00

396.14

ng/l

0.73

105

Disorders of eyelid, lacrimal system and orbit

309

1402

1.62

13.75

1.1

506.70

395.49

ng/l

0.17

398

Pneumonia, organism unspecified

330

1421

1.59

13.69

1.1

528.48

415.81

ng/l

0.21

369

Complications of medical and surgical care

266

1440

1.66

13.66

1.1

412.17

413.36

ng/l

0.00

402

All kidney diseases

352

1504

1.57

13.62

1.1

162.39

487.61

ng/l

1.82

391

Anxiety (asthma-related co-morbidities)

225

978

1.75

13.59

1.1

103.24

266.30

ng/l

0.96

278

Migraine with aura and triptan purchases

276

2.66

13.55

1.1

262.00

521.51

ng/l

0.34

Asthma (only as main-diagnosis), excluding more controls

226

705

1.78

13.36

1.1

70.63

488.89

ng/l

1.15

181

Other facial nerve disorders

6.39

13.31

1.0

1.1

86.50

31.50

ng/l

—

Dermatitis

229

1311

1.71

13.30

1.1

271.44

457.40

ng/l

0.54

352

Excluding asthma or asthma-COPD overlap

255

743

1.72

13.28

1.1

314.40

503.93

ng/l

0.35

190

Hypo-osmolality and hyponatraemia

288

2.60

13.27

1.1

538.17

349.71

ng/l

0.33

Other pulmonary diagnosis

254

743

1.72

13.05

1.1

307.68

503.93

ng/l

0.36

190

Any mental disorder

363

1166

1.56

12.94

1.1

421.69

347.64

ng/l

0.12

338

Temporal arteritis

5.66

12.91

1.2

1.1

45.00

63.89

ng/l

—

Septicaemia

148

695

1.95

12.91

1.1

691.00

468.13

ng/l

0.18

168

Other septicaemia, including avohilmo

136

641

2.00

12.83

1.1

747.95

500.44

ng/l

0.17

153

Diseases of oesophagus, stomach and duodenum

368

1414

1.54

12.75

1.1

194.18

458.06

ng/l

1.19

389

Alzheimer’s disease (Late onset), excluding more controls

4.78

12.74

1.1

51.80

297.40

ng/l

—

Asthma (only as main-diagnosis)

228

733

1.74

12.70

1.1

69.35

506.24

ng/l

1.29

189

Hypertensive diseases (excluding secondary)

187

591

1.84

12.68

1.1

136.77

251.86

ng/l

0.75

161

Transient ischemic attack

169

724

1.86

12.64

1.1

209.53

691.32

ng/l

1.20

203

All anxiety disorders

228

1039

1.71

12.62

1.1

103.24

280.62

ng/l

1.10

292

Depression or dysthymia

211

648

1.78

12.61

1.0

1.1

850.52

457.99

ng/l

0.34

199

Shoulder lesions

254

908

1.68

12.61

1.1

449.58

361.85

ng/l

0.12

271

Care involving use of rehabilitation procedures

226

1200

1.70

12.58

1.1

123.85

489.06

ng/l

1.84

311

Other joint disorders

310

1008

1.61

12.57

1.1

204.45

346.89

ng/l

0.63

294

Special screening examination for infectious and parasitic diseases

240

2.50

12.57

1.1

98.53

256.77

ng/l

0.99

Acute upper respiratory infections

359

1400

1.54

12.50

1.1

530.35

377.87

ng/l

0.25

387

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

188

1022

1.78

12.47

1.1

347.92

383.32

ng/l

0.04

272

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

304

1112

1.60

12.46

1.1

499.13

377.82

ng/l

0.21

292

304

1112

1.60

12.46

1.1

499.13

377.82

ng/l

0.21

292

Other anxiety disorders

173

805

1.83

12.43

1.1

149.85

301.87

ng/l

0.57

216

Benign neoplasm of brain and other parts of central nervous system

3.87

12.35

1.2

1.1

55.42

435.84

ng/l

0.78

Enthesopathies of lower limb, excluding foot

368

2.35

12.32

1.1

74.41

384.09

ng/l

0.93

110

Giant cell arteritis with polymyalgia rheumatica

5.41

12.32

1.2

1.1

45.00

45.13

ng/l

—

Other disorders of nervous system

3.77

12.27

1.2

1.1

200.33

504.68

ng/l

—

Lung diseases due to external agents

189

2.93

12.25

1.2

1.1

100.20

424.74

ng/l

1.23

Antihypertensive medication - note that there are other indications

215

641

1.76

12.13

1.1

110.75

176.04

ng/l

0.46

162

Lumbar disc prolapse

207

885

1.74

12.11

1.1

51.30

395.82

ng/l

1.55

268

Other heart diseases

171

603

1.85

11.98

1.1

779.21

252.07

ng/l

0.43

160

Factors influencing health status and contact with health services

191

2.42

11.94

1.1

1.0

202.82

240.11

ng/l

0.10

Other diseases of blood and blood-forming organs, wide

405

2.26

11.93

1.2

1.1

838.73

319.74

ng/l

0.38

101

Selective serotonin reuptake inhibitors

323

1072

1.57

11.90

1.1

334.98

368.87

ng/l

0.06

313

Other infectious diseases, including avohilmo

130

3.33

11.89

1.2

1.1

32.93

361.43

ng/l

1.01

Other and unspecified dermatitis

192

1108

1.74

11.85

1.1

301.33

483.90

ng/l

0.43

304

Other viral diseases, not elsewhere classified

349

2.35

11.82

1.1

96.72

277.99

ng/l

1.05

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

342

1414

1.53

11.77

1.2

1.1

432.14

404.75

ng/l

0.05

108

352

Other and unspecified myopathies

136

3.26

11.75

1.1

504.07

206.16

ng/l

0.31

Other septicaemia

130

631

1.95

11.49

1.1

787.66

495.33

ng/l

0.20

152

Benign neoplasm: Cerebral meninges

138

3.21

11.48

1.1

951.49

402.17

ng/l

—

Other shoulder lesions

133

3.25

11.47

1.1

66.70

318.19

ng/l

—

Other diseases of upper respiratory tract

365

1259

1.51

11.45

1.1

316.41

469.51

ng/l

0.34

108

331

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.70

11.43

1.3

1.1

2156.06

78.46

ng/l

0.88

Pneumonias (Asthma/COPD co-morbidities)

352

1526

1.51

11.42

1.1

492.95

395.61

ng/l

0.19

100

395

Undetermined asthma

186

2.86

11.37

1.2

1.1

289.00

268.96

ng/l

0.02

SLE (Finngen)

5.59

11.18

1.0

1.1

518.14

720.78

ng/l

—

All pneumoniae

353

1530

1.50

11.18

1.1

483.64

395.58

ng/l

0.17

100

395

Psychiatric diseases

316

1019

1.56

11.17

1.1

347.63

338.74

ng/l

0.02

298

Benign neoplasm of meninges

156

3.03

11.17

1.2

1.1

802.41

395.34

ng/l

0.22

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

345

1528

1.50

11.14

1.1

488.24

398.74

ng/l

0.17

101

392

Abnormal findings on diagnostic imaging of lung

160

844

1.80

11.10

1.1

132.07

655.40

ng/l

1.82

231

Fibromyalgia

126

3.27

11.06

1.1

26.29

310.18

ng/l

—

Undetermined asthma, excluding more controls

189

2.82

11.05

1.2

1.1

289.00

161.26

ng/l

0.20

Disorders of vestibular function (Vertigo)

163

892

1.78

11.03

1.1

367.48

526.00

ng/l

0.27

241

Giant cell arteritis

4.69

10.96

1.2

1.1

73.71

512.93

ng/l

—

Other diseases of urinary system

333

1230

1.52

10.96

1.1

598.98

286.18

ng/l

0.49

336

Symptoms and signs concerning food and fluid intake

127

3.24

10.88

1.1

221.38

166.91

ng/l

—

Brachial plexus disorders

148

3.06

10.87

1.1

293.92

365.06

ng/l

0.13

Hydrocephalus

103

3.52

10.86

1.2

1.1

385.40

457.44

ng/l

—

Chronic sinusitis

150

827

1.82

10.82

1.1

127.50

543.01

ng/l

1.20

217

Cough

146

745

1.83

10.75

1.1

891.37

274.65

ng/l

0.72

215

Follow-up examination after treatment for conditions other than malignant neoplasms

123

414

1.98

10.72

1.1

169.41

319.88

ng/l

0.45

121

Covid-19 suspected case

386

2.21

10.66

1.1

20.91

441.70

ng/l

1.24

100

Other arthritis (FG)

113

572

1.98

10.65

1.1

191.82

687.95

ng/l

1.03

158

Persons encountering health services in other circumstances, wide

378

1317

1.48

10.61

1.1

152.63

446.62

ng/l

2.07

103

342

Heartburn

172

2.87

10.56

1.1

108.25

230.07

ng/l

0.73

Acute sinusitis

188

1010

1.70

10.55

1.1

103.88

303.69

ng/l

1.31

282

Diseases of inner ear

186

1051

1.70

10.54

1.1

334.84

541.78

ng/l

0.44

290

Visual field defects

110

3.39

10.53

1.1

70.25

260.07

ng/l

—

Disorders of sclera, cornea, iris and ciliary body

194

1163

1.67

10.49

1.1

186.33

521.19

ng/l

1.24

307

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

314

1625

1.51

10.48

1.1

611.69

357.72

ng/l

0.29

423

Dermatitis and eczema

380

1542

1.46

10.39

1.1

330.83

426.95

ng/l

0.21

106

404

Agranulocytosis

185

2.78

10.36

1.2

1.1

1317.40

394.39

ng/l

0.41

Dementia, including avohilmo

151

569

1.81

10.17

1.1

55.90

627.59

ng/l

1.79

170

Persons encountering health services in other circumstances

149

831

1.78

10.05

1.1

866.39

390.48

ng/l

0.30

215

Diseases of the ear and mastoid process

377

1296

1.46

9.95

1.1

146.00

478.55

ng/l

1.49

343

Retention of urine

115

479

1.95

9.94

1.2

1.1

398.35

470.71

ng/l

0.07

142

Disorders of lipoprotein metabolism and other lipidaemias

271

1064

1.55

9.93

1.1

156.27

497.71

ng/l

1.27

281

Hard cardiovascular diseases

284

1094

1.54

9.92

1.1

115.16

423.60

ng/l

1.46

303

Migraine, single triptan purchase ok & required. ICD-code if available is included

264

1154

1.55

9.91

1.1

130.33

381.84

ng/l

1.07

323

Triptan medication for migraine, single purchase ok

264

1154

1.55

9.91

1.1

130.33

381.84

ng/l

1.07

323

Iridocyclitis

426

2.10

9.82

1.1

73.23

289.13

ng/l

1.81

109

Other and unspecified nerve root and plexus disorders, also in other diseases

361

2.20

9.80

1.0

1.1

154.05

445.77

ng/l

0.65

Other specified/unspecified arthritis

101

507

2.00

9.79

1.1

211.00

468.37

ng/l

0.63

149

Presence of other devices

387

2.14

9.77

1.2

1.1

699.93

297.06

ng/l

0.46

Coxibs

218

2.20

9.72

1.1

199.09

217.38

ng/l

0.04

Disorders of other endocrine glands

156

887

1.73

9.68

1.1

422.52

253.28

ng/l

0.35

234

Pure hypercholesterolaemia

246

996

1.57

9.62

1.1

218.57

528.32

ng/l

0.96

263

Somnolence, stupor and coma

4.33

9.59

1.3

1.0

22.20

66.24

ng/l

—

Hypertension, essential

259

941

1.56

9.56

1.1

205.80

325.88

ng/l

0.43

256

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.54

9.46

1.2

1.1

28.14

258.79

ng/l

—

Complications of procedures, not elsewhere classified

271

1443

1.51

9.42

1.1

63.46

485.49

ng/l

3.24

407

371

1304

1.44

9.32

1.1

509.51

376.70

ng/l

0.23

107

353

Other infectious diseases

104

3.29

9.29

1.2

1.1

35.75

442.64

ng/l

0.99

Dementia

136

513

1.82

9.26

1.1

65.22

602.97

ng/l

1.43

154

Hypothyroidism (congenital or acquired)

182

2.31

9.22

1.0

1.1

138.81

243.35

ng/l

0.34

Triptan medication for migraine, min. 3 purchases

196

901

1.63

9.20

1.1

102.84

262.33

ng/l

0.82

247

Gastrointestinal diseases

196

592

1.66

9.17

1.1

267.57

219.68

ng/l

0.14

170

Fall on same level

383

1433

1.43

9.13

1.1

189.29

473.82

ng/l

1.27

388

All influenza

479

1.99

9.12

1.2

1.1

694.52

373.17

ng/l

0.20

123

Chronic apical periodontitis

364

1423

1.44

9.09

1.1

365.90

431.06

ng/l

0.12

106

380

Other symptoms and signs involving the digestive system and abdomen

259

2.36

9.02

1.1

196.10

434.26

ng/l

0.35

Hypothyroidism, levothyroxine purchases

181

2.30

8.97

1.1

95.24

243.35

ng/l

0.56

Hypothyroidism and >3 levothyroxin purchases

181

2.30

8.97

1.1

95.24

243.35

ng/l

0.56

Arthropathies

299

1012

1.49

8.97

1.1

198.05

346.89

ng/l

0.67

294

Urinary track infection

193

584

1.66

8.96

1.1

659.53

113.28

ng/l

0.66

146

160

945

1.68

8.95

1.1

142.24

279.48

ng/l

0.59

247

Reactive arthropathies, FINNGEN

102

3.26

8.89

1.0

1.1

131.40

570.44

ng/l

—

Other specified/unspecified systemic involvement of connective tissue

3.73

8.89

1.1

1.2

62.00

450.06

ng/l

—

Chorioretinal inflammation

4.94

8.85

1.1

1.0

348.17

42.67

ng/l

—

Systemic lupus erythematosus

4.52

8.85

1.0

1.1

518.14

43.58

ng/l

—

Hypertensive diseases

262

971

1.52

8.81

1.1

214.56

317.17

ng/l

0.35

265

Hyperkinetic disorders, excluding more controls

187

2.55

8.78

1.1

20.33

135.40

ng/l

—

Other disorders of glucose regulation and pancreatic internal secretion

129

2.97

8.76

1.1

87.00

175.77

ng/l

—

Sleep apnoea

313

1353

1.46

8.74

1.1

467.72

346.75

ng/l

0.23

378

ILD medications: azathioprine

257

2.35

8.72

1.1

354.95

232.63

ng/l

0.24

Renal tubulo-interstitial diseases

289

1438

1.47

8.71

1.1

175.09

464.22

ng/l

1.45

381

Intestinal infectious diseases

315

1618

1.45

8.71

1.1

262.71

428.33

ng/l

0.55

428

Hypertension

261

970

1.52

8.67

1.1

214.56

317.17

ng/l

0.35

265

Hypothyroidism, drug reimbursement

125

2.69

8.53

1.1

79.43

57.63

ng/l

—

COPD/asthma related infections

323

1112

1.46

8.53

1.1

288.82

377.82

ng/l

0.21

292

COPD/asthma/ILD related infections

323

1112

1.46

8.53

1.1

288.82

377.82

ng/l

0.21

292

Polyarthropathies

218

896

1.56

8.49

1.1

391.75

373.57

ng/l

0.04

270

Mycoses

102

541

1.89

8.48

1.1

215.07

244.21

ng/l

0.11

140

Candidiasis, including avohilmo

108

585

1.85

8.42

1.1

227.24

339.84

ng/l

0.28

159

Diarrhoea and gastroenteritis of presumed infectious origin

235

1385

1.52

8.41

1.1

218.38

478.05

ng/l

0.81

364

Immunodeficiencies

3.59

8.41

1.3

1.1

631.70

195.57

ng/l

—

Conjunctivitis (acute, non atopic)

106

570

1.86

8.33

1.0

1.1

416.67

349.01

ng/l

0.08

157

Herpesviral [herpes simplex] infections, including avohilmo

489

1.93

8.30

1.1

239.90

351.29

ng/l

0.23

130

Adrenocortical insufficiency

4.12

8.27

1.0

1.1

161.00

49.57

ng/l

—

Any reimbursement code in KELA

193

598

1.62

8.24

1.1

144.90

344.12

ng/l

0.77

141

Presence of other functional implants

188

804

1.60

8.23

1.1

548.70

567.75

ng/l

0.02

206

Pain in thoracic spine

221

2.41

8.20

1.1

34.42

507.86

ng/l

0.97

Hypothyroidism, strict autoimmune

219

930

1.55

8.18

1.1

205.98

401.11

ng/l

0.53

234

Falls/tendency to fall

344

1209

1.43

8.17

1.1

201.69

382.63

ng/l

0.77

336

Azathioprine

265

2.27

8.16

1.2

1.1

354.95

311.67

ng/l

0.07

Nonorganic sleeping disorders, excluding more controls

371

2.06

8.04

1.1

98.33

343.28

ng/l

0.65

111

Vocal cord dysfunction

189

2.43

8.01

1.2

1.1

133.72

276.36

ng/l

0.64

Rheumatism, unspecified

194

2.49

7.95

1.1

289.16

324.57

ng/l

0.05

SLE, strict definition

4.30

7.95

1.1

451.50

54.54

ng/l

—

SLE, ICD10

4.30

7.95

1.1

451.50

54.54

ng/l

—

Hypoglycaemia, other or unspecified

3.15

7.95

1.1

80.86

225.50

ng/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

131

2.84

7.94

1.1

1973.54

150.84

ng/l

0.57

Injuries to the ankle and foot

245

1411

1.48

7.90

1.1

92.58

376.71

ng/l

2.61

392

Persons encountering health services for other counselling and medical advice, not elsewhere classified

349

1317

1.41

7.86

1.1

93.02

446.62

ng/l

3.14

342

Other disorders of adrenal gland

3.61

7.86

1.0

1.1

146.90

48.70

ng/l

—

Polyuria

402

2.00

7.83

1.1

221.23

475.81

ng/l

0.63

110

Other medical care

156

799

1.64

7.79

1.1

681.94

638.67

ng/l

0.03

212

Chronic diseases of tonsils and adenoids

258

1102

1.48

7.75

1.1

265.39

494.68

ng/l

0.57

286

Spinal stenosis

148

654

1.67

7.74

1.1

1126.43

446.79

ng/l

0.67

202

Inflammatory diseases of female pelvic organs

200

881

1.56

7.74

1.1

187.62

406.06

ng/l

0.52

228

Acute upper respiratory infections of multiple and unspecified sites

250

1234

1.48

7.74

1.1

707.13

378.47

ng/l

0.36

341

Other disorders of ear

297

1340

1.43

7.66

1.1

283.68

447.78

ng/l

0.41

368

Sleep disorders (combined)

349

1301

1.40

7.64

1.1

225.72

329.01

ng/l

0.43

358

Reactive arthropathies

140

2.73

7.59

1.1

115.83

363.70

ng/l

—

Anterior Iridocyclitis

373

2.02

7.57

1.1

70.85

287.99

ng/l

1.68

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

101

555

1.83

7.57

1.1

144.90

411.70

ng/l

0.88

144

Speech and linguistic disorders, excluding more controls

105

2.96

7.54

1.2

1.1

61.70

286.64

ng/l

—

Abnormalities of heart beat

117

651

1.75

7.54

1.1

846.20

298.53

ng/l

0.51

188

Other bacterial intestinal infections, including avohilmo

429

1.94

7.51

1.1

347.12

287.87

ng/l

0.12

117

Other/unspecified reactive arthropathies

108

2.99

7.50

1.0

1.1

131.40

219.89

ng/l

—

Tonsillectomy and adenotomy

189

844

1.56

7.45

1.1

281.42

281.90

ng/l

0.00

203

Diseases of arteries, arterioles and capillaries (FINNGEN)

280

2.00

7.45

1.1

24.43

295.73

ng/l

2.69

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

195

1253

1.53

7.39

1.1

90.31

441.53

ng/l

2.18

354

Unspecified/other endometriosis

139

2.69

7.37

1.2

1.1

27.00

57.77

ng/l

—

Irritable bowel syndrome

512

1.84

7.27

1.1

82.40

315.94

ng/l

0.80

140

Other strabismus

405

1.95

7.25

1.1

50.30

137.40

ng/l

1.38

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

134

798

1.66

7.23

1.1

111.90

280.15

ng/l

0.73

215

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

352

1.96

7.22

1.1

54.50

123.27

ng/l

0.59

Diseases of the respiratory system

194

623

1.56

7.21

1.1

364.21

601.40

ng/l

0.36

156

Acute tubulo-interstitial nephritis

203

1134

1.51

7.20

1.1

179.87

539.20

ng/l

1.43

305

Tobacco use

3.14

7.14

1.2

1.1

407.33

227.36

ng/l

—

Trochanteric bursitis

218

2.30

7.06

1.1

33.36

301.74

ng/l

2.20

Disorders of speech understanding and production

3.34

7.01

1.2

1.1

31.80

46.23

ng/l

—

Injuries to the shoulder and upper arm

278

1515

1.42

6.97

1.1

459.15

413.70

ng/l

0.06

423

Intestinal infectious diseases, including avohilmo, including avohilmo

369

1508

1.36

6.97

1.1

244.81

445.97

ng/l

0.74

408

Rotator cuff syndrome

188

845

1.53

6.90

1.1

464.27

384.62

ng/l

0.09

252

Neoplasms

247

886

1.46

6.88

1.1

131.83

309.31

ng/l

0.85

221

Disorders of choroid and retina

252

1224

1.44

6.87

1.1

181.73

544.99

ng/l

1.71

325

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

142

2.62

6.86

1.1

1974.45

403.21

ng/l

0.37

Cystitis

256

1054

1.45

6.86

1.1

193.23

293.25

ng/l

0.39

293

Disorders of psychological development

198

2.30

6.83

1.1

56.09

183.02

ng/l

0.84

Temporomandibular joint disorders, including avohilmo

150

916

1.59

6.78

1.1

166.71

245.03

ng/l

0.34

244

Problems related to lifestyle

191

2.37

6.77

1.1

267.09

187.62

ng/l

0.14

Acute and subacute iridocyclitis

348

1.99

6.75

1.1

68.69

287.95

ng/l

1.59

Sleep apnoea, including avohilmo

319

1394

1.38

6.75

1.1

483.46

431.36

ng/l

0.08

382

Zoster [herpes zoster], including avohilmo

162

1007

1.55

6.68

1.1

940.26

433.34

ng/l

0.34

274

Degenerative diseases of the nervous system

105

430

1.76

6.66

1.1

25.88

418.34

ng/l

2.16

127

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

116

2.78

6.63

1.1

23.22

324.20

ng/l

—

Conductive and sensorineural hearing loss

245

1129

1.44

6.63

1.1

397.44

514.86

ng/l

0.21

311

Substance abuse, excluding more controls

168

909

1.55

6.63

1.1

379.94

386.46

ng/l

0.01

268

Neuromuscular dysfunction of bladder

139

2.60

6.61

1.1

24.90

240.25

ng/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

3.12

6.59

1.1

12.67

249.13

ng/l

—

Specific development disorders of speech and language

2.93

6.57

1.2

1.0

84.83

116.83

ng/l

—

Osteopathies and chondropathies

181

1096

1.51

6.52

1.1

137.23

540.90

ng/l

1.79

299

Non-selective monoamine reuptake inhibitors

111

630

1.69

6.47

1.1

176.84

426.46

ng/l

0.81

190

Sacroiliitis, not elsewhere classified

3.66

6.47

1.2

1.1

676.20

305.12

ng/l

—

Deviated nasal septum

107

629

1.70

6.41

1.1

653.26

547.10

ng/l

0.08

166

Polymyalgia rheumatica

196

2.31

6.40

1.1

169.33

432.70

ng/l

—

Personality disorders, excluding more controls

446

1.84

6.37

1.1

39.48

277.21

ng/l

0.91

140

Other mental disorders due to brain damage and dysfunction and to physical disease

178

2.37

6.36

1.1

1106.67

394.07

ng/l

—

Constipation

284

1384

1.39

6.34

1.1

206.86

467.48

ng/l

1.10

391

Soft tissue disorders related to use, overuse and pressure

492

1.79

6.31

1.1

75.36

281.18

ng/l

2.15

148

External causes of morbidity and mortality

209

705

1.49

6.29

1.1

282.15

264.90

ng/l

0.04

201

Disorders of lens

204

855

1.48

6.29

1.2

1.1

353.87

552.12

ng/l

0.38

224

Dentofacial anomalies [including malocclusion]

232

1269

1.43

6.24

1.1

195.57

368.47

ng/l

0.63

341

Other bacterial intestinal infections

317

1.99

6.24

1.1

406.00

336.29

ng/l

0.11

Restless leg syndrome

257

2.11

6.21

1.1

2351.50

328.60

ng/l

0.43

Asthma (diagnoses ohter than nonallergic)

277

1616

1.39

6.21

1.1

168.54

450.22

ng/l

1.42

430

Bronchitis

341

1516

1.35

6.20

1.1

564.38

371.00

ng/l

0.30

422

Other and unspecified mononeuropathies, also in other diseases

5.06

6.19

1.1

17.83

362.32

ng/l

—

All influenza (not pneumonia)

251

2.12

6.17

1.2

1.1

1301.42

115.87

ng/l

0.45

Asthma-related infections

189

1250

1.48

6.15

1.1

213.61

458.82

ng/l

0.75

326

Asthma, hospital admission 2, infections

189

1250

1.48

6.15

1.1

213.61

458.82

ng/l

0.75

326

Sensorineural hearing loss

228

1057

1.44

6.15

1.1

451.74

529.48

ng/l

0.11

293

Hemiplegia

3.31

6.13

1.0

1.1

16.80

221.31

ng/l

—

Endocrine, nutritional and metabolic diseases

244

860

1.43

6.11

1.1

220.70

325.62

ng/l

0.32

215

Disorders of the thyroid gland

288

1355

1.38

6.09

1.1

340.16

352.69

ng/l

0.02

372

Other CVD (FINNGEN)

131

2.40

6.03

1.1

2318.00

329.15

ng/l

—

Chronic lower respiratory diseases

382

1518

1.33

6.02

1.1

324.44

425.05

ng/l

0.21

106

399

Hypopituitarism

140

2.52

6.01

1.0

1.1

443.33

119.73

ng/l

—

Tongue abnormality

2.94

6.00

1.1

180.38

463.54

ng/l

—

Internal derangement of knee

119

726

1.63

6.00

1.1

103.56

405.76

ng/l

1.56

221

Unspecified urinary incontinence

129

2.57

5.94

1.2

1.1

203.11

342.80

ng/l

—

Accidents

246

867

1.42

5.93

1.1

208.18

390.34

ng/l

0.61

251

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

256

2.08

5.89

1.1

1545.94

414.37

ng/l

0.43

Asthma, including avohilmo

372

1548

1.32

5.87

1.1

147.12

462.72

ng/l

1.75

411

Any dementia, excluding more controls

104

421

1.70

5.84

1.1

57.17

334.31

ng/l

1.41

122

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

113

693

1.63

5.84

1.1

559.82

317.59

ng/l

0.34

178

Use of hypnotics and sedatives

335

1428

1.34

5.83

1.1

527.39

318.15

ng/l

0.39

397

Diseases of tongue

2.83

5.83

1.1

180.38

218.13

ng/l

—

Intermittent heterotropia

2.83

5.81

1.0

1.1

55.50

242.15

ng/l

—

Other complications of surgical and medical care, not elsewhere classified

155

2.40

5.78

1.1

32.50

361.11

ng/l

1.09

Diseases of external ear

116

718

1.62

5.78

1.1

86.18

422.07

ng/l

1.61

190

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.32

5.77

1.1

1.0

1084.17

92.62

ng/l

—

Exposure to unspecified factor

322

1635

1.34

5.74

1.1

182.19

436.26

ng/l

1.14

447

Mouth breathing

129

821

1.57

5.69

1.1

337.87

523.09

ng/l

0.33

216

Disorders of muscles

144

2.44

5.68

1.0

1.1

11.67

348.95

ng/l

—

Other external causes of accidental injury

244

867

1.41

5.64

1.1

200.75

390.34

ng/l

0.65

251

Hypothyroidism, other/unspecified

265

1266

1.38

5.60

1.1

328.32

361.64

ng/l

0.06

356

Any death

195

941

1.45

5.59

1.1

801.48

518.40

ng/l

0.29

263

Use of rivastigmine

195

2.21

5.57

1.1

19.44

350.89

ng/l

—

Disturbance of activity and attention

242

2.06

5.56

1.1

20.33

129.76

ng/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

278

1335

1.36

5.56

1.1

304.54

355.65

ng/l

0.11

373

Osteoporosis

408

1.78

5.54

1.1

158.38

567.11

ng/l

0.68

113

Other diseases of arteries and capillaries

146

2.41

5.53

1.1

129.79

404.24

ng/l

—

Other and unspecified drugs and medicaments

140

2.44

5.53

1.1

1974.45

381.02

ng/l

0.38

Nonorganic sleeping disorders

425

1.79

5.51

1.1

98.33

216.47

ng/l

0.65

105

Diseases of pulp and periapical tissues, including avohilmo

315

1214

1.34

5.44

1.1

398.44

341.10

ng/l

0.11

318

Disorders of conjunctiva

264

1500

1.36

5.43

1.1

465.62

424.42

ng/l

0.05

398

Other cataract

128

606

1.57

5.42

1.1

453.98

683.49

ng/l

0.21

162

Voice disturbances

509

1.71

5.40

1.1

105.80

384.81

ng/l

1.03

140

Dermatitis due to substances taken internally

3.03

5.37

1.1

29.71

257.28

ng/l

—

Carpal tunnel syndrome

169

998

1.47

5.35

1.1

123.68

494.16

ng/l

1.60

288

Pain and other conditions associated with female genital organs and menstrual cycle

313

1.85

5.35

1.1

54.23

117.78

ng/l

0.85

Dyspnoea

277

1479

1.35

5.34

1.1

438.82

396.07

ng/l

0.07

399

Generalized anxiety disorder

273

1.98

5.31

1.1

17.64

291.33

ng/l

1.75

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

205

2.14

5.31

1.1

55.14

189.24

ng/l

—

Drug-induced neutropenia

119

2.54

5.29

1.2

1.1

2019.38

392.77

ng/l

0.49

Unspecified fall

159

1058

1.48

5.28

1.1

55.13

390.80

ng/l

2.57

291

Dental caries

441

1.74

5.24

1.0

1.1

148.39

328.81

ng/l

0.63

127

Other disorders of eyelid

131

805

1.54

5.24

1.2

1.1

473.50

471.11

ng/l

0.00

220

Localized swelling, mass and lump of skin and subcutaneous tissue

590

1.65

5.22

1.2

1.1

1254.11

287.08

ng/l

0.62

163

Other and unspecified anaemias

122

735

1.56

5.21

1.2

1.1

233.60

371.76

ng/l

0.53

194

Diabetic neuropathy

162

2.28

5.20

1.2

1.1

510.63

217.96

ng/l

—

Hypermobility syndrome

2.89

5.19

1.0

1.1

56.33

67.29

ng/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

464

1.73

5.19

1.2

1.1

70.94

291.58

ng/l

0.76

134

Conjunctivitis

240

1409

1.37

5.16

1.1

256.50

437.66

ng/l

0.47

373

Hyperkinetic disorders

263

1.97

5.13

1.1

20.33

127.90

ng/l

—

Diseases of the skin and subcutaneous tissue

302

1133

1.34

5.11

1.1

500.85

400.69

ng/l

0.12

298

Mycoses, including avohilmo

287

1642

1.33

5.05

1.1

249.53

428.30

ng/l

0.76

443

Other anaemias

122

739

1.55

5.03

1.2

1.1

233.60

371.76

ng/l

0.53

194

Budesonide

238

2.02

5.03

1.1

170.09

324.53

ng/l

0.38

Senile cataract

179

752

1.45

5.02

1.2

1.1

364.83

599.21

ng/l

0.43

202

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

120

2.47

5.01

1.2

1.1

18.14

217.73

ng/l

—

Chronic gastritis

453

1.73

5.00

1.1

182.22

575.18

ng/l

1.01

128

Disorders of mineral metabolism

147

2.32

5.00

1.1

15.18

208.30

ng/l

—

Enterocolitis due to Clostridium difficile

166

2.24

4.99

1.1

574.31

351.42

ng/l

0.26

Seronegative rheumatoid arthritis

179

2.19

4.98

1.1

157.60

389.13

ng/l

0.70

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

174

1213

1.43

4.97

1.1

96.54

496.13

ng/l

2.20

343

Functional dyspepsia

515

1.67

4.94

1.1

160.31

376.87

ng/l

0.55

140

Other disorders of white blood cells

2.75

4.94

1.2

1.1

64.82

231.58

ng/l

0.64

Other and unspecified disorders of skin and subcutaneous tissue

2.74

4.94

1.1

124.00

575.26

ng/l

—

Caries of dentine

388

1.77

4.93

1.1

157.12

347.53

ng/l

0.60

115

Aplastic and other anaemias

131

792

1.52

4.91

1.2

1.1

228.32

524.45

ng/l

1.08

213

Bacterial intestinal infections, IBD co-morbidities

317

1.87

4.91

1.1

398.00

375.99

ng/l

0.03

Pain associated with micturition

200

2.11

4.90

1.1

76.57

367.48

ng/l

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

314

1535

1.31

4.88

1.1

211.61

441.81

ng/l

0.86

411

Secondary uncertain malignant neoplasm

207

2.08

4.88

1.1

1915.53

390.64

ng/l

0.62

Speech and linguistic disorders

148

2.28

4.88

1.2

1.1

61.70

230.83

ng/l

—

Sleep disorders

282

1461

1.33

4.87

1.1

796.89

358.26

ng/l

0.36

395

Sequelae of infectious and parasitic diseases, including avohilmo

112

2.51

4.87

1.1

64.33

197.75

ng/l

0.59

Bleeding

249

1290

1.35

4.86

1.1

546.86

449.48

ng/l

0.13

350

Dental pulpitis, including avohilmo

288

1390

1.33

4.86

1.1

196.72

396.91

ng/l

0.86

379

Superficial injury of hip and thigh

248

1.98

4.85

1.1

98.45

320.58

ng/l

1.15

Fissure and fistula of anal and rectal regions

428

1.73

4.83

1.0

1.1

2045.12

578.82

ng/l

0.33

110

Acute generalized exanthematous pustulosis

3.01

4.83

1.1

35.00

208.68

ng/l

—

Chronic rhinitis, nasopharyngitis and pharyngitis

611

1.61

4.81

1.2

1.1

536.43

310.18

ng/l

0.17

160

Coagulation defects, purpura and other haemorrhagic conditions

348

1.82

4.81

1.2

1.1

1556.30

321.78

ng/l

0.71

Gluteal tendinitis

3.09

4.79

1.1

133.40

526.50

ng/l

—

Drug-induced adrenocortical insufficiency

5.28

4.78

1.0

1.1

127.40

54.83

ng/l

—

Impacted cerumen

189

2.13

4.77

1.1

56.92

458.53

ng/l

1.78

Oligomenorrhoea

3.60

4.77

1.3

1.0

98.80

58.00

ng/l

—

Injuries to the thorax

136

914

1.49

4.76

1.1

98.96

492.88

ng/l

2.45

260

Exposure to other specified factors

254

1630

1.34

4.74

1.1

144.92

447.00

ng/l

1.89

442

Behavioural syndromes associated with physiological disturbances and physical factors

292

1500

1.32

4.73

1.1

774.08

350.31

ng/l

0.36

409

Other heart diseases, wide

291

1333

1.32

4.73

1.1

528.51

363.07

ng/l

0.20

356

Injury of muscle and tendon at shoulder and upper arm level

108

693

1.56

4.71

1.1

942.96

537.55

ng/l

0.27

193

Osteoporosis with pathological fracture (FG)

2.72

4.67

1.1

41.50

352.38

ng/l

—

Residual foreign body in soft tissue

2.85

4.65

1.1

58.80

324.80

ng/l

—

Obesity related asthma

111

719

1.55

4.65

1.1

56.97

415.59

ng/l

1.82

190

Abnormal findings on diagnostic imaging of other body structures

239

1.97

4.62

1.2

1.1

820.12

419.62

ng/l

0.31

253

1.94

4.61

1.1

37.08

232.78

ng/l

1.23

Tuberculosis of other organs, strict, including avohilmo

5.51

4.61

1.3

1.1

202.50

109.40

ng/l

—

L04AA Selective immunosuppressants

442

1.70

4.60

1.1

105.31

435.58

ng/l

0.93

107

Paroxysmal tachycardia

327

1.76

4.60

1.1

1841.79

234.60

ng/l

0.53

Urticaria and erythema

116

762

1.52

4.56

1.1

467.46

312.44

ng/l

0.14

190

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

126

523

1.52

4.54

1.1

716.28

225.37

ng/l

0.48

145

Otalgia

141

2.28

4.53

1.2

1.1

7.82

407.76

ng/l

1.25

Continuous positive airway pressure

287

1.80

4.53

1.2

1.1

1295.90

258.14

ng/l

0.57

Benign paroxysmal vertigo

528

1.63

4.53

1.1

275.01

401.41

ng/l

0.28

141

Disorders of skin appendages

156

1084

1.43

4.51

1.1

67.33

334.07

ng/l

2.01

286

Other enthesopathies

536

1.63

4.51

1.1

1976.56

284.42

ng/l

0.40

164

Diaphragmatic hernia

106

686

1.55

4.47

1.1

256.92

542.08

ng/l

0.46

202

Glomerular diseases

328

1.80

4.44

1.1

128.75

347.18

ng/l

1.10

Hypokalaemia

195

2.06

4.43

1.2

1.1

248.56

382.71

ng/l

—

Misadventures to patients during surgical and medical care

243

1.94

4.42

1.1

264.90

404.58

ng/l

—

Hernia of abdominal wall, postoperative

255

1.91

4.42

1.0

1.1

134.56

177.44

ng/l

—

Other problems related to primary support group, including family circumstances

196

2.04

4.42

1.2

1.1

215.75

200.42

ng/l

0.03

Insomnia

273

1445

1.31

4.41

1.1

820.02

333.04

ng/l

0.39

389

Unspecific neurodegenerative disorder

113

503

1.54

4.40

1.1

30.12

588.45

ng/l

1.57

157

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

329

1.80

4.40

1.1

104.44

352.44

ng/l

0.50

Spondylopathies (FG)

223

1.98

4.38

1.1

347.70

361.30

ng/l

—

Insulin, fast-acting

108

706

1.53

4.36

1.1

221.97

347.36

ng/l

0.45

181

Sequelae of external causes of morbidity and mortality

465

1.66

4.34

1.0

1.1

105.67

335.96

ng/l

1.69

123

Sicca syndrome [Sjögren]

125

2.33

4.33

1.1

19.78

533.58

ng/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

239

1.93

4.28

1.1

1965.64

451.32

ng/l

0.36

Injury, poisoning and certain other consequences of external causes

159

553

1.44

4.27

1.1

346.64

355.04

ng/l

0.01

150

Endometriosis

354

1.60

4.27

1.1

350.62

177.71

ng/l

0.25

Spondyloarthritis

296

1.83

4.27

1.1

317.18

312.15

ng/l

0.01

Cardiac arrhythmias

179

821

1.40

4.25

1.1

928.30

336.86

ng/l

0.42

226

Other female pelvic inflammatory diseases

275

1.86

4.25

1.1

481.00

494.33

ng/l

0.01

Deforming dorsopathies

460

1.65

4.24

1.1

51.00

554.79

ng/l

1.13

146

Dermatophytosis

240

1.92

4.23

1.0

1.1

106.13

327.12

ng/l

1.02

Tinnitus

438

1.67

4.23

1.0

1.1

920.71

473.42

ng/l

0.34

114

Hyperlipidaemia, other/unspecified

111

660

1.51

4.20

1.1

185.85

691.21

ng/l

1.30

179

Chronic lymphocytic leukaemia

3.44

4.19

1.1

66.20

48.99

ng/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

3.44

4.19

1.1

66.20

48.99

ng/l

—

Chronic lymphocytic leukaemia, helper endpoint

3.44

4.19

1.1

66.20

48.99

ng/l

—

Cluster headache, wide

3.43

4.18

1.0

—

43.55

—

Purpura and other haemorrhagic conditions

227

1.94

4.18

1.3

1.1

2200.79

372.74

ng/l

0.76

6-mercaptopurine

3.44

4.18

1.2

1.1

432.12

198.50

ng/l

—

Use of pramipexole

380

1.72

4.15

1.1

3265.62

314.21

ng/l

0.65

104

Asthma and allergy

184

2.04

4.14

1.2

1.1

28.75

510.02

ng/l

—

Diabetic retinopathy, excluding more controls

231

1.72

4.14

1.1

202.87

311.06

ng/l

0.40

Disorders of calcium metabolism

103

2.44

4.13

1.1

15.18

249.31

ng/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

241

1223

1.32

4.12

1.1

191.63

368.36

ng/l

0.57

332

Asthma and allergy, excluding more controls

185

2.03

4.09

1.2

1.1

28.75

509.85

ng/l

—

Streptococcal septicaemia

129

2.26

4.05

1.2

1.1

129.42

302.25

ng/l

0.50

Other acute lower respiratory infections

157

1067

1.40

4.05

1.1

570.21

341.79

ng/l

0.26

283

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

2.52

4.05

1.1

64.82

237.72

ng/l

0.61

Congenital malformations and deformations of the musculoskeletal system

161

2.11

4.03

1.1

49.80

221.85

ng/l

—

Abnormal findings on examination of blood, without diagnosis

138

871

1.44

4.02

1.1

169.81

542.08

ng/l

1.68

239

Disease of hard tissues of teeth, NOS

154

564

1.43

4.02

1.1

111.38

299.86

ng/l

1.10

168

Tuberculosis of other organs, strict

5.05

4.01

1.3

1.1

202.50

109.40

ng/l

—

Thrombocytopenia, unspecified

117

2.32

4.01

1.3

1.1

1721.42

215.40

ng/l

0.62

Asthma, hospital admissions , main diagnosis only

244

1622

1.31

3.99

1.1

120.00

452.80

ng/l

2.09

437

Volume depletion

130

2.24

3.98

1.1

2149.73

404.17

ng/l

0.43

Noninfective enteritis and colitis

141

991

1.42

3.98

1.1

180.83

382.69

ng/l

0.79

263

Use of anticholinesterases

436

1.58

3.96

1.1

36.59

421.26

ng/l

2.11

128

N06DA Anticholinesterases

436

1.58

3.96

1.1

36.59

421.26

ng/l

2.11

128

Other CVD

311

1.77

3.95

1.1

1362.75

373.73

ng/l

0.36

Thyroiditis, ILD-related definition

177

2.04

3.93

1.1

63.88

457.60

ng/l

—

Acute bronchitis

118

790

1.47

3.91

1.1

723.50

303.72

ng/l

0.41

202

Any dementia

104

473

1.52

3.90

1.1

57.17

404.61

ng/l

2.02

139

Benign neoplasm of colon, rectum, anus and anal canal

180

1116

1.36

3.89

1.1

329.63

548.42

ng/l

0.54

316

Insulin, fast-acting or short human

108

725

1.49

3.89

1.1

221.97

332.93

ng/l

0.40

190

Other diseases of intestine

262

1.84

3.88

1.1

83.33

574.52

ng/l

—

Other retinal disorders

182

1014

1.36

3.88

1.1

196.21

597.51

ng/l

1.50

269

Benign neoplasms

288

1218

1.29

3.88

1.1

294.51

361.99

ng/l

0.17

323

Streptococcal septicaemia, including avohilmo

132

2.21

3.85

1.2

1.1

129.42

302.25

ng/l

0.50

Injuries to the knee and lower leg

356

1536

1.25

3.85

1.1

576.79

356.87

ng/l

0.26

100

406

Bipolar affective disorders

344

1.72

3.83

1.1

40.06

165.47

ng/l

1.49

Diabetic maculopathy, excluding more controls

179

2.02

3.83

1.1

156.56

332.73

ng/l

—

Genitourinary diseases

171

617

1.39

3.81

1.1

96.91

235.97

ng/l

1.02

151

Melanocytic naevi of trunk

221

1.91

3.81

1.1

133.63

354.19

ng/l

—

Spondylolisthesis/Spondylolysis

271

1.81

3.81

1.1

38.82

474.91

ng/l

1.00

Missing teeth due to accident, extraction or parodontitis

182

1201

1.35

3.80

1.1

731.29

458.93

ng/l

0.31

332

Generalized skin eruption due to drugs and medicaments

2.85

3.79

1.1

35.00

227.59

ng/l

—

Varicella [chickenpox], including avohilmo

2.48

3.79

1.2

1.1

98.20

179.87

ng/l

—

Superficial injury of head

444

1.62

3.77

1.0

1.1

215.36

303.90

ng/l

0.34

116

Sequelae of infectious and parasitic diseases

108

2.32

3.75

1.2

1.1

71.80

212.34

ng/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

116

785

1.46

3.75

1.1

566.37

379.08

ng/l

0.22

218

Abnormal weight loss

147

2.12

3.74

1.1

256.17

356.59

ng/l

—

Excessive, frequent and irregular menstruation

107

378

1.51

3.73

1.1

49.24

173.18

ng/l

1.67

Insulin, intermediate and long-acting

156

1090

1.38

3.73

1.1

121.52

480.36

ng/l

2.52

296

Tuberculosis, wide, including avohilmo

2.45

3.71

1.3

1.1

167.00

88.00

ng/l

—

Cluster headache, strict

3.61

3.70

1.0

1.1

—

43.55

—

Superficial injury of abdomen, lower back and pelvis

290

1.76

3.63

1.1

491.75

304.36

ng/l

0.19

Allergic contact dermatitis

225

1.87

3.62

1.2

1.1

641.00

236.18

ng/l

—

Viral and other specified intestinal infections, including avohilmo

515

1.55

3.62

1.1

9.10

237.63

ng/l

—

129

Diseases of arteries, arterioles and capillaries

186

1015

1.34

3.62

1.1

64.72

600.97

ng/l

2.81

291

Striking against or struck by other objects

106

720

1.47

3.62

1.1

1970.72

256.57

ng/l

0.41

200

Vasomotor and allergic rhinitis

109

729

1.46

3.60

1.1

416.39

328.92

ng/l

0.08

179

Crohn disease

240

1.84

3.59

1.2

1.1

195.63

341.78

ng/l

0.30

Disorders of adult personality and behaviour

577

1.53

3.59

1.1

431.96

305.59

ng/l

0.15

152

Vitamin deficiency

2.76

3.59

1.1

46.80

254.33

ng/l

—

Vitamin deficiency, wide

2.76

3.59

1.1

46.80

254.33

ng/l

—

Speech therapy

483

1.58

3.56

1.1

93.50

496.88

ng/l

1.44

126

Varicella [chickenpox]

2.58

3.55

1.2

1.1

98.20

186.00

ng/l

—

Thyroiditis

111

2.26

3.54

1.1

16.67

471.15

ng/l

—

Menorrhagia

343

1.53

3.51

1.1

69.21

179.98

ng/l

1.14

Other disorders of patella

286

1.75

3.50

1.1

359.33

450.53

ng/l

0.09

Candidiasis

264

1.79

3.50

1.1

461.37

308.91

ng/l

—

Special screening examination for other diseases and disorders

151

2.06

3.49

1.2

1.1

89.64

183.68

ng/l

0.56

Transplanted organ and tissue status

172

1.98

3.48

1.1

661.26

310.56

ng/l

0.24

Mental and behavioural disorders due to psychoactive substance use

173

1181

1.34

3.46

1.1

379.94

418.07

ng/l

0.04

314

Disorders of vitreous body

144

993

1.38

3.45

1.1

694.13

546.76

ng/l

0.12

274

Bacterial, viral and other infectious agents

152

2.05

3.45

1.1

2369.77

158.97

ng/l

—

Crohn's disease NAS

106

2.27

3.45

1.1

15.80

294.62

ng/l

—

Hypotension

258

1.79

3.44

1.1

2030.25

426.03

ng/l

—

Non-allergic asthma (mode), excluding more controls

285

1.74

3.43

1.0

1.1

102.83

432.29

ng/l

—

Acetic acid derivatives and related substances

209

1.66

3.42

1.1

500.76

222.72

ng/l

0.33

Atopic dermatitis

178

1060

1.34

3.42

1.1

68.27

274.71

ng/l

1.71

273

Other specified/unspecified inflammatory spondylopathies

2.77

3.42

1.1

10.17

480.29

ng/l

—

Other and unspecified tonsillitis

100

564

1.48

3.39

1.1

636.45

212.93

ng/l

0.43

150

Tuberculosis, wide

2.40

3.39

1.2

1.1

167.00

88.00

ng/l

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.59

3.38

1.1

122.20

241.99

ng/l

—

Other symptoms and signs involving the urinary system

167

1.98

3.38

1.1

98.14

412.35

ng/l

—

Open wound of head

154

1064

1.36

3.38

1.1

177.34

590.78

ng/l

1.33

291

Benign neoplasm of other and unspecified endocrine glands

238

1.81

3.37

1.2

1.1

83.47

321.06

ng/l

1.12

Diabetic maculopathy

177

1.93

3.37

1.1

156.56

168.74

ng/l

—

Other diseases of anus and rectum

544

1.52

3.36

1.0

1.1

555.72

482.87

ng/l

0.07

141

Impingement syndrome of shoulder

420

1.60

3.35

1.1

91.40

506.49

ng/l

1.94

127

Keratitis

105

726

1.45

3.33

1.1

309.89

350.67

ng/l

0.07

188

Elevated blood glucose level

134

2.10

3.33

1.1

366.40

190.31

ng/l

—

Ptosis of eyelid

189

1.91

3.33

1.2

1.1

842.40

245.00

ng/l

—

Non-allergic asthma (mode)

288

1.72

3.32

1.0

1.1

102.83

512.53

ng/l

—

Lesion of ulnar nerve

211

1.85

3.29

1.0

1.1

15.00

320.61

ng/l

—

Colonic or urogenital fistula

517

1.53

3.29

1.1

1847.71

464.48

ng/l

0.36

128

Substance abuse

168

1170

1.33

3.27

1.1

379.94

419.29

ng/l

0.04

313

Insulin, combination of fast acting with intermediate-acting or long-acting

172

1174

1.33

3.25

1.1

170.48

458.65

ng/l

1.73

312

Disorders of vitreous body and globe

145

1007

1.36

3.23

1.1

694.13

539.11

ng/l

0.13

278

Other disorders of bone

362

1.63

3.23

1.1

125.27

307.08

ng/l

0.69

Lymphoid leukaemia

2.39

3.22

1.1

625.50

208.47

ng/l

—

Crohn's disease of small intestine

116

2.16

3.22

1.2

1.1

20.11

299.72

ng/l

—

Dementia in other diseases classified elsewhere

2.59

3.21

1.1

194.00

106.33

ng/l

—

Achilles tendinitis

150

2.01

3.19

1.2

1.1

88.83

252.94

ng/l

—

Benign neoplasm: Colon

150

1042

1.35

3.19

1.1

408.71

548.69

ng/l

0.25

299

Weight loss

164

1.96

3.18

1.1

256.17

358.23

ng/l

—

Erysipelas

147

934

1.36

3.17

1.1

255.29

512.86

ng/l

0.65

234

Assault by bodily force

130

2.08

3.17

1.1

697.60

124.90

ng/l

—

Sequelae of other and unspecified infectious and parasitic diseases

2.32

3.17

1.1

73.22

237.72

ng/l

—

Urticaria

627

1.47

3.16

1.1

49.89

315.29

ng/l

1.28

164

Infections with a predominantly sexual mode of transmission

602

1.48

3.14

1.1

52.53

309.06

ng/l

1.14

157

Personality disorders

547

1.50

3.14

1.1

39.48

329.39

ng/l

1.15

140

Benign neoplasm of eye and adnexa

172

1.93

3.13

1.1

2624.71

403.08

ng/l

0.41

Heterophoria

131

2.07

3.11

1.0

1.1

60.83

204.63

ng/l

—

Diverticular disease of intestine

197

940

1.31

3.11

1.1

307.83

467.80

ng/l

0.37

253

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

159

1.96

3.08

1.2

1.1

133.80

348.25

ng/l

—

Bacterial, viral and other infectious agents, including avohilmo

166

1.94

3.08

1.1

2369.77

150.70

ng/l

—

Superficial injury of lower leg

517

1.51

3.08

1.1

32.13

393.94

ng/l

1.46

133

Focal brain injury

3.68

3.08

1.1

79.80

149.67

ng/l

—

Ovarian cyst

359

1.48

3.07

1.1

988.36

179.42

ng/l

0.40

Diabetic retinopathy, strict definition

230

1.74

3.07

1.1

150.46

228.81

ng/l

0.27

Reimbursement for rheumatic diseases

163

1224

1.32

3.06

1.1

353.46

483.83

ng/l

0.24

331

Crohn disease (strict definition, require KELA, min 2 HDR)

2.23

3.06

1.1

31.00

314.63

ng/l

—

Allergic asthma (mode)

351

1.61

3.05

1.1

34.53

335.72

ng/l

0.68

Other disorders of bladder

188

1.87

3.05

1.1

1459.36

421.02

ng/l

0.32

Other and unspecified disorders of white blood cells

2.60

3.04

1.3

1.1

42.25

218.61

ng/l

—

Injuries to the wrist and hand

301

1617

1.23

3.04

1.1

959.18

310.26

ng/l

0.67

436

Excessive attrition of teeth

180

1366

1.31

3.04

1.0

1.1

186.53

372.02

ng/l

0.81

377

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

529

1.50

3.02

1.1

140.32

349.74

ng/l

0.53

129

Other skin changes

330

1.64

3.02

1.1

314.37

445.79

ng/l

0.17

Pre-eclampsia

346

1.62

3.01

1.0

1.1

203.31

407.10

ng/l

0.32

Tuberculosis, IBD comorbidity

2.31

3.00

1.3

1.1

167.00

88.00

ng/l

—

Other and unspecified psoriasis

113

2.13

3.00

1.0

1.1

1620.20

258.55

ng/l

—

Childhood asthma (age<16), excluding more controls

140

1.90

3.00

1.1

79.00

63.90

ng/l

—

Explicit bacterial Sepsis

154

1.95

2.98

1.2

1.1

131.92

495.87

ng/l

1.01

Other noninfective gastroenteritis and colitis

473

1.52

2.97

1.1

196.00

300.66

ng/l

0.24

117

Other diseases of pleura

116

724

1.39

2.97

1.1

279.74

488.46

ng/l

0.55

199

Allergic asthma (mode), excluding more controls

354

1.60

2.95

1.1

34.53

335.79

ng/l

0.73

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

114

2.11

2.94

1.0

1.1

80.00

242.00

ng/l

—

Sudden idiopathic hearing loss

155

1.94

2.94

1.2

1.1

1479.18

478.40

ng/l

0.55

Crohn disease (strict definition, require KELA)

101

2.19

2.93

1.1

31.00

314.63

ng/l

—

Aneurysms, operations, SAH

272

1.70

2.93

1.0

1.1

255.57

309.45

ng/l

—

Coronary artery bypass grafting

363

0.51

2.93

1.2

1.1

2088.17

322.77

ng/l

0.67

107

Other disorders of skin and subcutaneous tissue

207

1369

1.28

2.92

1.1

483.15

427.83

ng/l

0.05

384

Social phobias

121

2.07

2.91

1.0

1.1

13.44

257.00

ng/l

—

Drug-induced cataract

3.47

2.90

1.0

1.1

51.00

99.43

ng/l

—

Emotionally unstable personality disorder

221

1.77

2.88

1.2

1.1

22.71

124.45

ng/l

—

Nontraumatic intracranial haemmorrhage

296

1.66

2.88

1.1

1306.42

315.32

ng/l

0.43

Transport accidents

129

790

1.36

2.85

1.1

59.56

394.60

ng/l

2.07

232

Statin medication

195

850

1.29

2.84

1.1

308.26

401.98

ng/l

0.20

233

Other and unspecified urticaria

375

1.58

2.84

1.2

1.1

53.17

240.58

ng/l

1.60

Melanocytic naevi

609

1.45

2.84

1.1

136.47

350.53

ng/l

0.80

165

Other and unspecified iron deficiency

649

1.43

2.84

1.1

789.56

381.65

ng/l

0.23

171

Explicit bacterial Sepsis, including avohilmo

157

1.92

2.84

1.2

1.1

131.92

494.72

ng/l

1.04

Childhood asthma (age<16)

143

1.86

2.83

1.1

79.00

62.92

ng/l

—

Conjunctivitis (acute, non atopic), including avohilmo

298

1467

1.23

2.83

1.1

184.94

432.04

ng/l

0.97

402

Retinal detachments and breaks

651

1.43

2.83

1.1

103.44

652.12

ng/l

2.25

173

Pruritus

186

1.83

2.82

1.0

1.1

2398.78

283.45

ng/l

—

Meralgia paraesthetica

2.78

2.82

1.0

1.2

25.80

294.23

ng/l

—

Malignant neoplasm of digestive organs

583

0.62

2.81

1.1

68.20

605.29

ng/l

—

153

Monoamine oxidase A inhibitors

179

1.85

2.81

1.1

—

334.62

—

Dislocation, sprain and strain of joints and ligaments of knee

181

1269

1.29

2.81

1.1

397.70

406.59

ng/l

0.01

334

Hypermetropia

123

2.04

2.80

1.1

106.43

260.76

ng/l

—

Glomerulonephritis

165

1.89

2.80

1.1

143.30

318.84

ng/l

—

Attention to artificial openings

2.65

2.79

1.0

1.1

61.00

213.58

ng/l

—

Diseases of the digestive system

122

890

1.36

2.79

1.1

583.62

445.27

ng/l

0.13

242

Complications of internal orthopaedic prosthetic devices, implants and grafts

377

1.57

2.78

1.1

211.77

495.06

ng/l

0.80

105

Gonarthrosis

174

753

1.31

2.76

1.1

712.14

411.20

ng/l

0.28

229

Dental operations

161

626

1.32

2.76

1.1

349.43

238.09

ng/l

0.29

179

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

355

1.47

2.75

1.1

62.29

94.56

ng/l

0.26

Fracture of rib(s), sternum and thoracic spine

572

1.45

2.75

1.1

40.93

389.56

ng/l

2.40

159

Diabetic retinopathy

360

1.47

2.74

1.1

190.63

267.69

ng/l

0.37

108

Diseases of salivary glands

647

1.42

2.74

1.1

67.17

341.61

ng/l

1.32

172

Viral pneumonia

210

1.77

2.73

1.1

100.83

161.70

ng/l

—

Other obstetric conditions, not elsewhere classified

367

1.46

2.72

1.1

60.06

95.80

ng/l

0.31

Diseases of male genital organs

146

549

1.34

2.71

1.1

448.65

261.92

ng/l

0.43

148

Maternal care for other conditions predominantly related to pregnancy

362

1.56

2.71

1.1

33.42

358.63

ng/l

0.67

Iron deficiency anaemia

113

809

1.37

2.70

1.1

616.89

326.72

ng/l

0.21

214

Other peripheral vascular diseases

125

2.01

2.70

1.0

1.1

22.13

445.73

ng/l

—

Metatarsalgia

139

1.95

2.69

1.1

—

286.38

—

Dental caries, including avohilmo

199

796

1.28

2.68

1.1

359.00

397.95

ng/l

0.07

218

Meniscus derangement

151

759

1.32

2.68

1.2

1.1

281.83

413.70

ng/l

0.38

227

All chronic kidney diseases

151

916

1.32

2.67

1.1

186.35

633.06

ng/l

1.52

250

Other disorders of penis

175

1.83

2.66

1.0

1.1

39.00

342.18

ng/l

—

Insulin medication

172

1107

1.29

2.66

1.1

170.48

547.75

ng/l

1.55

296

Oxicams

194

1.61

2.66

1.2

1.1

73.85

229.13

ng/l

0.79

Other and unspecified effects of external causes

560

1.45

2.65

1.1

44.72

319.98

ng/l

1.25

155

Unspecified haematuria

110

651

1.38

2.64

1.1

1022.64

403.36

ng/l

0.57

184

Other diseases of stomach and duodenum

106

2.08

2.62

1.1

66.50

469.10

ng/l

—

Alcohol abuse, main dg, excluding more controls

251

1.68

2.61

1.1

78.17

219.08

ng/l

1.07

Sequelae with surgical and medical care as external cause

360

1.56

2.60

1.0

1.1

117.58

335.55

ng/l

1.43

Phlebitis and thrombophlebitis (not including DVT)

408

1.52

2.59

1.2

1.1

1168.81

181.05

ng/l

0.49

102

Early lumbar disc prolapse, operated

134

1.95

2.59

1.0

1.1

18.89

245.56

ng/l

—

Other fall from one level to another

440

1.50

2.59

1.1

625.11

262.58

ng/l

0.40

112

Use of donepezil

254

1.65

2.58

1.2

1.1

47.01

618.41

ng/l

—

Type 1 diabetes

497

1.47

2.58

1.1

217.62

364.04

ng/l

0.48

132

Type 2 diabetes, wide definition

229

1159

1.25

2.58

1.1

141.12

492.73

ng/l

1.54

316

Other abnormal uterine and vaginal bleeding

279

1.55

2.57

1.2

1.1

416.16

126.04

ng/l

0.67

Other diseases of hard tissues of teeth

147

575

1.33

2.57

1.1

230.47

298.51

ng/l

0.21

169

FESS (DNB20)

222

1.72

2.56

1.3

1.1

286.47

299.85

ng/l

0.02

Other (seronegative) rheumatoid arthritis, wide

322

1.59

2.56

1.1

141.53

308.19

ng/l

0.78

Alcohol use disorder, Swedish definition

151

1054

1.30

2.56

1.1

230.66

481.24

ng/l

0.56

284

Brain meningioma

2.36

2.55

1.2

2131.17

152.62

ng/l

—

Erysipelas, including avohilmo

192

1123

1.27

2.55

1.1

221.20

477.95

ng/l

0.86

282

Asthma-related pneumonia or sepsis

680

1.39

2.53

1.1

224.96

431.26

ng/l

0.42

174

Asthma, hospital admissions 3, pneumonia

680

1.39

2.53

1.1

224.96

431.26

ng/l

0.42

174

Caries of dentine, including avohilmo

213

865

1.26

2.53

1.1

319.19

378.39

ng/l

0.13

230

Gonarthrosis [arthrosis of knee](FG)

201

916

1.26

2.51

1.1

644.12

538.76

ng/l

0.10

263

Alzheimer’s disease, strict definition

291

1.55

2.51

1.2

1.1

30.30

576.47

ng/l

—

Nutritional anaemias

130

936

1.32

2.51

1.1

503.23

445.47

ng/l

0.04

256

Other follicular disorders

129

1.94

2.50

1.1

26.60

200.03

ng/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

461

1.48

2.49

1.1

108.50

259.73

ng/l

—

117

Malignant neoplasm of digestive organs, including Hilmo

623

0.66

2.48

1.1

117.46

567.30

ng/l

1.08

164

Brain meningioma, including Hilmo

2.33

2.48

1.2

2131.17

142.28

ng/l

—

Phobic anxiety disorders

209

1.72

2.47

1.1

17.10

239.00

ng/l

—

Scleritis and episcleritis

102

2.07

2.47

1.0

1.1

17.20

276.00

ng/l

—

Diseases of pulp and periapical tissues and dental caries

174

694

1.29

2.47

1.1

406.31

444.64

ng/l

0.06

183

Bitten or struck by other mammals

210

1.72

2.45

1.1

64.83

293.77

ng/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.56

2.44

1.0

1.1

—

389.08

—

Other arrhythmias

184

1087

1.26

2.43

1.1

745.40

389.40

ng/l

0.44

301

Fracture of foot, except ankle

480

1.46

2.43

1.2

1.1

91.92

354.02

ng/l

0.89

132

Other pleural conditions

152

1.85

2.42

1.1

77.71

375.39

ng/l

—

Other symptoms and signs involving the circulatory and respiratory systems

103

2.05

2.41

1.2

1.1

19.75

226.54

ng/l

—

Benign neoplasm: Choroid

110

2.01

2.40

1.1

3936.11

410.51

ng/l

—

Other peripheral vertigo

138

1.89

2.40

1.1

128.83

393.73

ng/l

—

Malignant neoplasm, wide definition

246

1167

1.23

2.40

1.1

603.86

369.03

ng/l

0.29

294

Intracerebral haemorrhage

167

1.80

2.39

1.1

1516.74

385.47

ng/l

0.42

Later onset COPD

376

0.55

2.39

1.1

141.00

476.25

ng/l

—

102

Other and unspecified injuries of ankle and foot

2.35

2.39

1.2

1.1

18.86

103.99

ng/l

—

Nonsuppurative otitis media

388

1.48

2.38

1.1

109.82

203.74

ng/l

0.47

Fall on and from stairs and steps

515

1.44

2.38

1.1

87.08

276.60

ng/l

1.48

128

Asthma-related pneumonia

680

1.38

2.38

1.1

232.00

431.26

ng/l

0.39

174

Specific personality disorders

466

1.46

2.37

1.1

48.06

354.57

ng/l

1.05

125

Schizophrenia or delusion, excluding more controls

534

1.43

2.35

1.0

1.1

168.58

368.37

ng/l

0.59

160

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

111

1.99

2.35

1.1

31.00

281.40

ng/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

575

1.41

2.34

1.2

1.1

70.94

306.82

ng/l

0.94

151

Otitis externa

451

1.47

2.34

1.1

104.55

276.46

ng/l

1.22

117

Nonsuppurative otitis media, including avohilmo

561

1.39

2.33

1.1

92.00

202.79

ng/l

0.89

132

Disorders of synovium and tendon

138

900

1.30

2.33

1.2

1.1

69.08

355.29

ng/l

3.03

274

Heart failure and coronary heart disease

601

0.67

2.32

1.1

471.79

326.45

ng/l

0.23

179

168

1154

1.27

2.32

1.1

220.91

439.25

ng/l

0.51

314

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS